Avalon GloboCare Submits Listing Application for The NASDAQ Capital Market

Genetics Investing

Avalon GloboCare (OTCQB:AVCO), a leading global developer of cell-based technologies, announced today it has filed an application for listing on the NASDAQ Capital Market. As quoted in the press release: “Over the past year, we have made significant strides in developing and commercializing innovative and transformative cell-based technologies. We believe we are well positioned to …

Avalon GloboCare (OTCQB:AVCO), a leading global developer of cell-based technologies, announced today it has filed an application for listing on the NASDAQ Capital Market.

As quoted in the press release:

“Over the past year, we have made significant strides in developing and commercializing innovative and transformative cell-based technologies. We believe we are well positioned to continue our growth and our plans to list on the Nasdaq Capital Market should provide us greater exposure as we execute on upcoming milestones,” stated David Jin, M.D., Ph.D., CEO and President of Avalon GloboCare Corp.

Click here to read the full press release.

application avalon globocare us Genetics Investing